EUROFINS SCIENT (OTCMKTS:ERFSF) Sees Unusually-High Trading Volume - Should You Buy?

Key Points

• EUROFINS SCIENT experienced a notable 512% increase in trading volume, with approximately 8,911 shares traded compared to 1,456 shares in the previous session.
• The stock's last traded price was $70.21, down from a previous close of $71.33, while analysts have mostly rated it as a "Hold."
• Citigroup restated a "neutral" rating on EUROFINS SCIENT, highlighting a consensus rating of "Hold" from one Strong Buy and five Hold ratings by equities research analysts.

Shares of EUROFINS SCIENT (OTCMKTS:ERFSF - Get Free Report) saw unusually-high trading volume on Tuesday . Approximately 8,911 shares were traded during trading, an increase of 512% from the previous session's volume of 1,456 shares.The stock last traded at $70.21 and had previously closed at $71.33.

Analyst Upgrades and Downgrades

Separately, Citigroup restated a "neutral" rating on shares of EUROFINS SCIENT in a research report on Friday, July 25th. One equities research analyst has rated the stock with a Strong Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, EUROFINS SCIENT has a consensus rating of "Hold".

EUROFINS SCIENT Stock Performance

The firm's fifty day simple moving average is $76.45 and its 200 day simple moving average is $67.95. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.26 and a quick ratio of 1.19.

About EUROFINS SCIENT

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.